Trials / Unknown
UnknownNCT03286023
Stereotactic Radiotherapy for Brain Metastases
Stereotactic Radiotherapy for Patients With Brain Metastases
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 110 (actual)
- Sponsor
- Centre Francois Baclesse, Luxembourg · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Stereotactic radiotherapy is an innovative treatment enabling to target accurately brain metastases. The aim of this study is to evaluate tumoral response and acute and late toxicity of this treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| RADIATION | stereotactic radiotherapy | stereotactic radiotherapy for brain metastases |
Timeline
- Start date
- 2014-10-01
- Primary completion
- 2019-10-01
- Completion
- 2022-12-01
- First posted
- 2017-09-18
- Last updated
- 2022-06-22
Locations
1 site across 1 country: Luxembourg
Source: ClinicalTrials.gov record NCT03286023. Inclusion in this directory is not an endorsement.